CalAIM CalAIM in Focus
Explore CHCF’s collection of tools and resources aimed at helping organizations understand and implement CalAIM.
Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
‘I Am Just Waiting to Die’: Social Security Clawbacks Drive Some Into Homelessness
The Social Security Administration is reclaiming billions of dollars in alleged overpayments from some of the nation's poorest and most vulnerable, leaving some people homeless or struggling to stay in housing, beneficiaries and advocates say.
Patients Facing Death Are Opting for a Lifesaving Heart Device — But at What Risk?
The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database contains more than 4,500 reports in which the medical device may have caused or contributed to a patient’s death.
When a Quick Telehealth Visit Yields Multiple Surprises Beyond a Big Bill
For the patient, it was a quick and inexpensive virtual appointment. Why it cost 10 times what she expected became a mystery.
New Doula Benefit ‘Life-Changing’ for California Mom
Doulas, independent workers who act as advocates for birthing parents, have been shown to help prevent pregnancy complications and improve the health of both mothers and babies. California’s Medicaid program started covering their services this year, but some doulas say bureaucratic obstacles and inadequate pay prevent their effective use.
Social Security Chief Apologizes to Congress for Misleading Testimony on Overpayments
Acting Commissioner Kilolo Kijakazi sent the letter days after KFF Health News and Cox Media Group reported that the agency has been demanding money back from more than twice as many people as she’d disclosed in October testimony.
‘They See a Cash Cow’: Corporations Could Consume $50 Billion of Opioid Settlements
As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?